Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is steadily advancing its patented DehydraTECH(TM) technology for a growing range of applications including oral nicotine, hypertension, antivirals, human hormone therapy, diabetes and…
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share…
D-Wave (NYSE: QBTS) is a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers. The company has announced important research results that demonstrate successful Quantum Error Mitigation (“QEM”)…
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border and domestic shipping within the…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting on its financial results for third quarter,…
Diamond Lake Minerals (OTC: DLMI), which specializes in the development and support of digital assets and SEC-registered security tokens, was featured on Benzinga’s All-Access. Diamond Lake’s CEO Brian Esposito joined the program to discuss his…
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, allowing for the creation of rich data for artificial intelligence…
Turbo Energy (NASDAQ: TURB), a leader in photovoltaic energy storage, was featured in an interview with Proactive London after the Spain-based company completed its Nasdaq listing in the U.S. Turbo Energy’s General Manager Mariano Soria…
SuperCom (NASDAQ: SPCB), a leading global provider of traditional and digital identity solutions, provides advanced safety, identification, connectivity, and security products and solutions to governments as well as public and private organizations around the world.…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today released financial results for the first quarter of the fiscal year 2024, which ended…
SuperCom Ltd. (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT and cybersecurity sectors, today announced financial and operating results for the three and nine months ended Sept. 30, 2023. “We are…
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services as well as the world’s first commercial supplier of quantum computers, has announced support for new Congressional legislation. According to the announcement,…
Longeveron (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide…
In the U.S., the rates of autism spectrum disorder (“ASD”), a diverse group of early-onset and lifelong neurodevelopmental conditions, have more than quadrupled from 2000 to 2020, according to data published by the Centers for…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is evaluating the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for the treatment of diabetes and weight loss.…
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, is reporting its numbers for the third quarter of 2023. Highlights of the report included revenue of $2.6 million for the quarter,…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a new high-energy facility in Fullerton, California, which expands the company’s overall U.S. footprint, including EV battery development and production capabilities. According to…
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-Related Frailty, is reporting on data from a long-term…